A new study has evaluated the effectiveness of different treatment options for basal cell carcinoma. Learn more.

During a Case-Based Roundtable® event, Natalie Galanina, MD, discussed data from the ZUMA-7 and TRANSFORM trials in the first ...

Clinical research suggests that combining a novel agent called navtemadlin with DNA-damaging chemotherapy for the treatment of glioblastoma, a form of brain cancer, could increase efficacy.

In a real-world analysis of patients with advanced RCC, the combination of first-line Bavencio and Inlyta was effective and ...

Patients with advanced urothelial carcinoma had prolonged survival with Bavencio and BSC treatment, regardless of diabetes ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Hundreds of people in England with aggressive blood cancer are set to benefit from an innovative new treatment that ...